Keyword
Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Does Re-entering the Cell Cycle Help Neurons Survive? | ALZFORUM
2 Orphazyme's arimoclomol fails a phase III in ALS
3 Inslee announces two-week pause on phases
4 Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 | NEJM
5 Phase I Vista Test Underground Mine and Vista Mine Phase II Expansion Projects
6 'It's getting pretty hot'
7 Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: Results of the Setouchi Lung Cancer Group Study 1301
8 Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update
9 NASA's Ingenuity Mars Helicopter to Begin New Demonstration Phase
10 Would S'pore have avoided a return to phase 2 if it had shut the borders early?
11 AstraZeneca's Tremelimumab Offers Survival Benefit With IMFINZI in Advanced Lung Cancer
12 FDA’s Acceleron Notice and a New Era of Enforcement for Results Reporting
13 US, China to assess Phase 1 deal soon, Biden trade chief says
14 Longeveron Announces Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer's Disease
15 Four COVID-19 vaccines are being tested in children and teens. Here's when different age groups could become eligible for shots.
16 Adagio's COVID-19 antibody marches on to phase 2/3 after early data suggest 12 months of protection
17 Clinical Catch-Up: April 5-9
18 Possible Phase Rollbacks Could Impact HS Sports Season
19 FDA Adcom Almost Evenly Split Vote on ChemoCentryx's Vasculitis Drug
20 Isotopic evidence for acidity-driven enhancement of sulfate formation after SO2 emission control
21 PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stability
22 Cell And Gene Therapy Clinical Trials Market in 2021 | Expansive Coverage on the Latest Developments in the Market
23 Here's what you can and can't do during each phase of Saskatchewan's reopening roadmap
24 BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer
25 Genmab A/S (GMAB) Q1 2021 Earnings Call Transcript
26 Programmable Bloch polaritons in graphene
27 India-China relations going through a 'very difficult phase': S Jaishankar
28 609th AOC optimizes ATO production, first to use KRADOS operationally
29 Poll: No surprise that majority supports Inslee's decision to pause phase adjustment; what is stunning are number of people who disagree
30 Brazil's Sao Paulo extends COVID-19 restriction phase, but eases commercial activity
31 St. Tammany property transfers, April 12-16, 2021: See a list of home and other sales
32 US'' HDT Bio Corp. begins Phase I/II trial of COVID-19 vaccine in India
33 Longeveron's Stem Cell Therapy Shows Potential in Phase 1 Trial
34 Jeffers gearing up for next phase of Journal Square project: 141 units of market-rate housing
35 Sarepta's Second Muscular Dystrophy Drug Shows Greater Promise in Phase II
36 Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
37 Orland Park Triangle Project enters new phase with action on development plan
38 Athira Pharma is Living Legacy to Founder's Legendary Mother
39 COVID‐19: vaccine's progress
40 In a surprise, Merck's Keytruda redeems itself in stomach cancer with Herceptin combo first-line nod
41 Palisade Bio and Newsoara Announce Completion of Phase 2 Study in GI Surgery Study in China
42 Aptinyx Resumes Trial of NYX-458, Potential Parkinson's Treatment
43 MCU Phase 4 Already Has One King in Black Link | Screen Rant
44 Tiziana Announces Strategic Initiative with Takanawa Japan KK, Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Ad
45 Tuscan Village Salem opens phase 2 Memorial Day weekend
46 Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant | NEJM
47 TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy
48 AstraZeneca unblinded South Africa Phase I/II to administer vaccine
49 Beshear, Coleman Announce $21.6M Grant Expanding Assistance for Kentucky's Newly Injured, Ill Workers to Remain on the Job
50 Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
51 A supportive offshore wind industry sees Biden's 2030 goal as ambitious
52 Lipidor
53 A viral genome packaging motor transitions between cyclic and helical symmetry to translocate dsDNA
54 ST News Night: A return to phase 2 in S'pore
55 ST News Night: S'pore returns to phase 2 of reopening amid rising Covid-19 cases
56 Restoration of City Park's 100-year-old Sullivan Gateway now complete
57 Gym owners in S'pore worry about rental costs, wages as studios close due to tighter Covid-19 curbs
58 Wine giant Gallo close to $400 million center in S. Carolina
59 Cell cycle inertia underlies a bifurcation in cell fates after DNA damage
60 North Platte Area Chamber & Development Corp. opens applications for 'Shot in the Arm' program
61 Peter Mørch Eriksen resigns as CEO of BioPorto A/S
62 Jury chooses life without parole over death for St. Louis man convicted of triple murder
63 Gennova starts enrolment for Phase I/II human trials for its mRNA vaccine
64 Therapeutic strategies to fight COVID‐19: Which is the status artis?
65 S'pore 'effectively' back in Phase 2: Lawrence Wong
66 H.A.N.D.S. brings new affordable housing to east Erie gateway neighborhood
67 State moving to ‘Bridge Phase’
68 Global Hyaluronic Acid-based Dermal Fillers Market Report 2021: Market to Reach $5.8 Billion by 2027
69 Quantum mechanics–free subsystem with mechanical oscillators
70 S.Korea to begin producing Novavax COVID-19 vaccine as early as June
71 New books: May 2021
72 Singapore stocks fall at open on Phase 2 reversion; STI down 0.8%
73 BioAge Signs Exclusive Agreement With Amgen To Develop and Commercialize Amgen's Phase 1 APJ Agonist To Treat Diseases of Aging
74 Realizing a 14% single-leg thermoelectric efficiency in GeTe alloys
75 AACR: Sanofi's engineered IL-2 clears safety hurdles in early phase 1 data
76 Vaxart's Covid-19 vaccine shows cross-coronavirus activity in trial
77 Cooper-Standard Holdings Inc (CPS) Q1 2021 Earnings Call Transcript
78 BRCA2 3'-UTR polymorphism rs15869
79 Otsuka and Lundbeck Announce Decision to Continue Phase III Clinical Trial Evaluating Brexpiprazole for Treatment of Agitation in Patients With Alzheimer's-type Dementia
80 Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
81 Optogenetic pacing of medial septum parvalbumin-positive cells disrupts temporal but not spatial firing in grid cells
82 Ensysce Biosciences' Covistat Subsidiary “At Home Coronavirus Pill”
83 Novo Nordisk A/S (NVO) Q1 2021 Earnings Call Transcript
84 Physicists Edge Closer to Taming the Three-Body Problem
85 Mus81-Eme1–dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrity
86 Correlative operando microscopy of oxygen evolution electrocatalysts
87 BATMAN team's support of SBIR project increases combat survival potential
88 Worldwide Peptide Cancer Vaccine Industry to 2026
89 Real-Time ETRM Capabilities: What’s The Value Add & Key Challenges?
90 Role of cell cycle on analyzing telomerase activity with a fluorescence off-on system
91 EDB New Ventures launches S$10m pilot programme to drive corporate innovation
92 Back to phase 2: Cap of 5 people for social gatherings from May 8 amid rising Covid-19 cases
93 Enanta Pharmaceuticals Inc (ENTA) Q2 2021 Earnings Call Transcript
94 Rashba valleys and quantum Hall states in few-layer black arsenic
95 LiveWest: Charity begins at home(s) by keeping close eye on costs
96 Protein that helps cancer cells to survive
97 Electrochemically controlled metasurfaces with high-contrast switching at visible frequencies
98 Vaccine update: issue 319, April 2021, COVID-19 phase 2 special edition
99 Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
100 Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia